Research Articles

Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites

Using a flow cytometry-based parasite growth inhibition assay (GIA) and an antibody-dependent cellular inhibition (ADCI) assay, we have assessed the differential effect and interaction of monocytes, immune sera, and purified immunoglobulins from Kenyan adults on the growth of Plasmodium falciparum parasites in vitro. We found that monocytes from 14 different normal, healthy, non-malaria-exposed donors had varying effects on parasite growth, i.e., inhibition or enhancement of parasitemia, suggesting heterogeneity in anti-parasitic activities of monocytes from individual donors. Twenty-two serum samples collected from clinically immune adults from western Kenya inhibited growth of P. falciparum after 48 hr in culture. In contrast, all IgG preparations, except one, purified from the same serum samples enhanced parasite growth. In ADCI experiments, of the 22 purified IgG samples used, 11 showed ADCI activities with specific growth inhibition (SGI) of more than 10%, with the highest at 27.6%, and the remaining 11 IgG samples had an SGI of less than 10%. Our results also showed that the ratio of IgG1 to IgG3 antibodies, as determined by an indirect immunofluorescence assay, was higher in the high ADCI response group than in the low response group, suggesting that a higher concentration of IgG1 antibodies with a higher IgG1/IgG3 ratio might be associated with ADCI activities. The present study has resulted in the development of simple, reproducible flow cytometry-based GIA and ADCI assays, and also provides baseline information for further investigation of the role of ADCI activity in naturally acquired immune protection against malaria.

This article has been cited by other articles:

				F. Sanderson, L. Andrews, A. D. Douglas, A. Hunt-Cooke, P. Bejon, and A. V. S. Hill Blood-stage Challenge for Malaria Vaccine Efficacy Trials: A Pilot Study with Discussion of Safety and Potential Value Am J Trop Med Hyg, June 1, 2008; 78(6): 878 - 883. [Abstract] [Full Text] [PDF]

				A. Jafarshad, M. H. Dziegiel, R. Lundquist, L. K. Nielsen, S. Singh, and P. L. Druilhe A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII J. Immunol., March 1, 2007; 178(5): 3099 - 3106. [Abstract] [Full Text] [PDF]

				R. Lundquist, L. K. Nielsen, A. Jafarshad, D. SoeSoe, L. H. Christensen, P. Druilhe, and M. H. Dziegiel Human Recombinant Antibodies against Plasmodium falciparum Merozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic Properties. Infect. Immun., June 1, 2006; 74(6): 3222 - 3231. [Abstract] [Full Text] [PDF]

				T. Scorza, K. Grubb, P. Smooker, A. Rainczuk, D. Proll, and T. W. Spithill Induction of Strain-Transcending Immunity against Plasmodium chabaudi adami Malaria with a Multiepitope DNA Vaccine Infect. Immun., May 1, 2005; 73(5): 2974 - 2985. [Abstract] [Full Text] [PDF]

				E. A. Ohas, J. H. Adams, J. N. Waitumbi, A. S. S. Orago, A. Barbosa, D. E. Lanar, and J. A. Stoute Measurement of Antibody Levels against Region II of the Erythrocyte-Binding Antigen 175 of Plasmodium falciparum in an Area of Malaria Holoendemicity in Western Kenya Infect. Immun., February 1, 2004; 72(2): 735 - 741. [Abstract] [Full Text] [PDF]

				S. Mahanty, A. Saul, and L. H. Miller Progress in the development of recombinant and synthetic blood-stage malaria vaccines J. Exp. Biol., November 1, 2003; 206(21): 3781 - 3788. [Abstract] [Full Text] [PDF]

				A. BOLAD, I. NEBIE, N. CUZIN-OUATTARA, A. TRAORE, F. ESPOSITO, and K. BERZINS ANTIBODY-MEDIATED IN VITRO GROWTH INHIBITION OF FIELD ISOLATES OF PLASMODIUM FALCIPARUM FROM ASYMPTOMATIC CHILDREN IN BURKINA FASO Am J Trop Med Hyg, June 1, 2003; 68(6): 728 - 733. [Abstract] [Full Text] [PDF]

				O. Garraud, R. Perraut, A. Diouf, W. S. Nambei, A. Tall, A. Spiegel, S. Longacre, D. C. Kaslow, H. Jouin, D. Mattei, et al. Regulation of Antigen-Specific Immunoglobulin G Subclasses in Response to Conserved and Polymorphic Plasmodium falciparum Antigens in an In Vitro Model Infect. Immun., June 1, 2002; 70(6): 2820 - 2827. [Abstract] [Full Text] [PDF]

				C. Oeuvray, M. Theisen, C. Rogier, J.-F. Trape, S. Jepsen, and P. Druilhe Cytophilic Immunoglobulin Responses to Plasmodium falciparum Glutamate-Rich Protein Are Correlated with Protection against Clinical Malaria in Dielmo, Senegal Infect. Immun., May 1, 2000; 68(5): 2617 - 2620. [Abstract] [Full Text] [PDF]

				D. L. Narum, J. D. Haynes, S. Fuhrmann, K. Moch, H. Liang, S. L. Hoffman, and B. K. L. Sim Antibodies against the Plasmodium falciparum Receptor Binding Domain of EBA-175 Block Invasion Pathways That Do Not Involve Sialic Acids Infect. Immun., April 1, 2000; 68(4): 1964 - 1966. [Abstract] [Full Text] [PDF]

				L. M. Kumaratilake and A. Ferrante Opsonization and Phagocytosis of Plasmodium falciparum Merozoites Measured by Flow Cytometry Clin. Vaccine Immunol., January 1, 2000; 7(1): 9 - 13. [Abstract] [Full Text] [PDF]